JOHNSON B KRISTINE 4
4 · AtriCure, Inc. · Filed May 20, 2026
Research Summary
AI-generated summary of this filing
AtriCure Director Kristine B. Johnson Receives Award
What Happened
Kristine B. Johnson, a director of AtriCure, received a grant of 6,144 restricted shares on May 18, 2026. The shares were acquired at $0.00 (a compensation award), so no cash was paid; total reported acquisition value is $0. This was a grant/award (not an open-market purchase or sale).
Key Details
- Transaction date: 2026-05-18; Filing date: 2026-05-20 (appears timely within the 2-business-day reporting window).
- Security: Common stock; Shares acquired: 6,144; Price per share: $0.00; Reported value: $0.
- Shares owned after transaction: Not specified in the filing.
- Footnote: The shares were issued under the AtriCure, Inc. 2023 Stock Incentive Plan as a Restricted Stock Award and will vest on the one-year anniversary of the grant (May 18, 2027).
- Transaction code: A (award/grant/acquisition).
Context
Restricted stock awards are compensation and vest over time; they signal executive/director pay rather than an immediate market buy or sell. Because these shares vest in one year, Johnson will not have full ownership until vesting conditions are met.
Insider Transaction Report
Form 4
AtriCure, Inc.ATRC
JOHNSON B KRISTINE
Director
Transactions
- Award
Common Stock
[F1]2026-05-18+6,144→ 55,954 total
Footnotes (1)
- [F1]The Reporting Person acquired these shares pursuant to a Restricted Stock Award under the AtriCure, Inc. 2023 Stock Incentive Plan. The shares will vest upon the one-year anniversary of the grant date.
Signature
/s/ Allison Walker as Attorney-in-fact for B. Kristine Johnson|2026-05-20